AdvertisementEli Lilly Ends Antibody Trial In Hospitalized COVID-19 Patients, Other Trials Go OnOctober 26, 2020Vanessa RomofacebookEmailIn this photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis, Ind. On Monday, U.S. government officials announced they are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it is unlikely to help. (AP)